TickerFacts.

Acro Biomedical Co., Ltd. (ACBM): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

60.04M
Year ended 2025-12-31
0.0%
3-year compound annual growth
+4.7%
5-year compound annual growth
2020-12-31: 47.76M2021-12-31: 53.84M2022-12-31: 60.04M2023-12-31: 60.04M2024-12-31: 60.04M2025-12-31: 60.04M60.04M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3160.04M0.0%2026-02-11, From 2025-01-01
2024-12-3160.04M0.0%2026-02-11, From 2024-01-01
2023-12-3160.04M0.0%2025-07-24, From 2023-01-01
2022-12-3160.04M+11.5%2025-07-18, From 2022-01-01
2021-12-3153.84M+12.7%2022-04-15, From 2021-01-01
2020-12-3147.76Mn/a2022-04-15, From 2020-01-01